PROVECTUS BIOPHARMACEUTICALS, INC. Contracts & Agreements
102 Contracts & Agreements
- Business Finance (52 contracts)
- Business Operations (6)
- Human Resources (25)
- Intellectual Property (1)
- Uncategorized (18)
- Form of Common Stock Option Agreement for Officers (Filed With SEC on December 5, 2024)
- Form of Common Stock Option Agreement for Independent Directors (Filed With SEC on December 5, 2024)
- Raines Employment Agreement, dated December 3, 2024, between the Company and Heather Raines (Filed With SEC on December 5, 2024)
- Form of Unsecured Convertible Promissory Note (Filed With SEC on July 17, 2024)
- 2024 Financing Term Sheet (Filed With SEC on July 17, 2024)
- Conversion Agreement, dated June 21, 2024, by and between the Company and Dominic Rodrigues (Filed With SEC on June 25, 2024)
- Pershing Employment Agreement, dated April 16, 2024, between the Company and Ed Pershing (Filed With SEC on April 16, 2024)
- Rodrigues Employment Agreement, dated April 16, 2024, between the Company and Dominic Rodrigues (Filed With SEC on April 16, 2024)
- Description of Securities (Filed With SEC on March 28, 2024)
- Exclusive License Agreement (with Equity), dated March 21, 2024, by and between the Company and University of Miami (Filed With SEC on March 27, 2024)
- Independent Contractor and Director Fee Termination Agreement and Release, dated March 25, 2024, between the Company and Bruce Horowitz (Filed With SEC on March 26, 2024)
- Independent Contractor Agreement, dated March 25, 2024, between the Company and Dominic Rodrigues (Filed With SEC on March 26, 2024)
- Description of Securities (Filed With SEC on March 30, 2023)
- 2022 Financing Term Sheet (Filed With SEC on November 9, 2022)
- Form of Unsecured Convertible Promissory Note (Filed With SEC on September 26, 2022)
- Description of Securities (Filed With SEC on March 29, 2022)
- 2021 Financing Term Sheet (Filed With SEC on November 10, 2021)
- Form of Unsecured Convertible Promissory Note (Filed With SEC on August 18, 2021)
- Description of Securities (Filed With SEC on March 2, 2021)
- Indemnification Agreement between the Company and Webster Bailey, effective as of July 20, 2020 (Filed With SEC on July 16, 2020)
- Description of Securities (Filed With SEC on March 5, 2020)
- 2020 Definitive Financing Term Sheet (Filed With SEC on March 5, 2020)
- Form of PRH 2 Secured Convertible Promissory Note (Filed With SEC on January 7, 2020)
- Executive Employment Agreement between the Company and Eric A. Wachter, Ph.D., dated May 17, 2019 (Filed With SEC on May 20, 2019)
- Amendment to the Independent Contractor Agreement dated April 19, 2017 between the Company and Bruce Horowitz, dated May 8, 2019 (Filed With SEC on May 9, 2019)
- Employment Agreement between the Company and Heather Raines, dated March 25, 2019 (Filed With SEC on March 25, 2019)
- Secured Convertible Promissory Note between the Company and Edward V. Pershing, dated July 26, 2018 (Filed With SEC on July 30, 2018)
- Second Amendment to Amended and Restated Secured Convertible Promissory Note between the Company and Eric Wachter, Ph.D., dated January 22, 2018 (Filed With SEC on May 9, 2018)
- Third Amendment to Amended and Restated Secured Convertible Promissory Note between the Company and Eric Wachter, Ph.D., dated January 22, 2018 (Filed With SEC on May 9, 2018)
- Fourth Amendment to Amended and Restated Secured Convertible Promissory Note between the Company and Eric Wachter, Ph.D., dated January 22, 2018 (Filed With SEC on May 9, 2018)
- First Amendment to Amended and Restated Secured Convertible Promissory Note between the Company and CAL Enterprises LLC, dated January 22, 2018 (Filed With SEC on May 9, 2018)
- Indemnification Agreement between the Company and Ed Pershing, dated April 19, 2018 (Filed With SEC on April 24, 2018)
- Indemnification Agreement between the Company and Jack Lacey, MD, dated April 19, 2018 (Filed With SEC on April 24, 2018)
- Convertible Promissory Note between the Company and Timothy C. Scott, dated February 23, 2018 (Filed With SEC on February 26, 2018)
- Secured Convertible Promissory Note between the Company and Eric A. Wachter, dated January 25, 2018 (Filed With SEC on January 30, 2018)
- AMENDMENT NO. 1 TO THE INDEPENDENT CONTRACTOR AGREEMENT (Filed With SEC on August 9, 2017)
- CONFIDENTIAL AMENDED AND RESTATEDDEFINITIVE FINANCING COMMITMENT TERM SHEET TO PROVECTUS BIOPHARMACEUTICALS,INC. DATED EFFECTIVE: March 19, 2017 (Filed With SEC on May 10, 2017)
- INDEPENDENT CONTRACTOR AGREEMENT (Filed With SEC on April 20, 2017)
- SECURED CONVERTIBLE PROMISSORY NOTE (this Note) (Filed With SEC on April 4, 2017)
- AMENDED AND RESTATED SECURED CONVERTIBLE PROMISSORY NOTE (this Note) (Filed With SEC on April 4, 2017)
- INDEMNIFICATION AGREEMENT (Filed With SEC on April 4, 2017)
- INDEMNIFICATION AGREEMENT (Filed With SEC on April 4, 2017)
- AMENDMENT NO. 1 TO THE INDEPENDENT CONTRACTOR AGREEMENT (Filed With SEC on March 31, 2017)
- CONVERTIBLE PROMISSORY NOTE (this Note) (Filed With SEC on February 21, 2017)
- PROVECTUS BIOPHARMACEUTICALS, INC. DEALER-MANAGER AGREEMENT January 30, 2017 (Filed With SEC on February 3, 2017)
- PROVECTUS BIOPHARMACEUTICALS, INC. DEALER-MANAGER AGREEMENT January , 2017 (Filed With SEC on January 26, 2017)
- WARRANT AGENCY AGREEMENT (Filed With SEC on January 26, 2017)
- PROVECTUS BIOPHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on January 26, 2017)
- FORM OF NON-TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE (Filed With SEC on January 19, 2017)
- FORM OF NON-TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE (Filed With SEC on December 6, 2016)
- FORM OF NON-TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE (Filed With SEC on November 1, 2016)
- FORM OF NON-TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE (Filed With SEC on October 5, 2016)
- WARRANT AGENCY AGREEMENT (Filed With SEC on August 30, 2016)
- Form of Warrant PROVECTUS BIOPHARMACEUTICALS, INC. SERIES A WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 25, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 25, 2016)
- SECOND AMENDMENT TO WARRANT AGENCY AGREEMENT (Filed With SEC on May 13, 2016)
- EXCHANGE ANDESCROW AGENT AGREEMENT (Filed With SEC on May 13, 2016)
- INDEPENDENT CONTRACTOR AGREEMENT (Filed With SEC on April 22, 2016)
- FIRST AMENDMENT TO WARRANT AGENCY AGREEMENT (Filed With SEC on December 31, 2015)
- EXCHANGE AND ESCROW AGENT AGREEMENT (Filed With SEC on December 31, 2015)
- CONSENT AND WAIVER OF RIGHTS (Filed With SEC on June 24, 2015)
- 17,500,000 SHARES OF COMMON STOCK AND 17,500,000WARRANTS OF PROVECTUS BIOPHARMACEUTICALS, INC. UNDERWRITING AGREEMENT (Filed With SEC on June 19, 2015)
- WARRANT AGENCY AGREEMENT (Filed With SEC on June 19, 2015)
- [FORM OF COMMON STOCK WARRANT CERTIFICATE] (Filed With SEC on June 19, 2015)
- IN THE CIRCUIT COURT FOR KNOX COUNTY, TENNESSEE (Filed With SEC on August 7, 2014)
- AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on April 30, 2014)
- AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on April 30, 2014)
- AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on April 30, 2014)
- AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on April 30, 2014)
- PROVECTUS BIOPHARMACEUTICALS, INC. Up to $50,000,000 of Shares ofCommon Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on April 30, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 13, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 13, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 13, 2014)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 13, 2014)
- PURCHASE AGREEMENT (Filed With SEC on July 26, 2013)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2013)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2013)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2013)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2013)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 28, 2013)
- WARRANT (Filed With SEC on February 28, 2013)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 28, 2013)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2012)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2012)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2012)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2012)
- WARRANT (Filed With SEC on April 20, 2011)
- WARRANT (Filed With SEC on April 20, 2011)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 16, 2011)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 16, 2011)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 16, 2011)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 16, 2011)
- [FORMOF SERIES A WARRANT] PROVECTUSPHARMACEUTICALS, INC. WarrantTo Purchase Common Stock (Filed With SEC on January 13, 2011)
- [FORMOF SERIES B WARRANT] PROVECTUSPHARMACEUTICALS, INC. WarrantTo Purchase Common Stock (Filed With SEC on January 13, 2011)
- [FORMOF SERIES C WARRANT] PROVECTUSPHARMACEUTICALS, INC. WarrantTo Purchase Common Stock (Filed With SEC on January 13, 2011)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on January 13, 2011)
- COMMONSTOCK PURCHASE WARRANT PROVECTUSPHARMACEUTICALS, INC. (Filed With SEC on December 23, 2010)
- PURCHASEAGREEMENT (Filed With SEC on December 23, 2010)
- REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on December 23, 2010)
- SECURITIES PURCHASEAGREEMENT (Filed With SEC on March 12, 2010)
- WARRANT (Filed With SEC on March 12, 2010)
- REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on March 12, 2010)
